Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+74.7%
5Y CAGR-3.3%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+74.7%/yr
vs -21.1%/yr prior
5Y CAGR
-3.3%/yr
Recent acceleration
Acceleration
+95.8pp
Accelerating
Percentile
P82
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 55.91% |
| 2024 | 13.98% |
| 2023 | 24.24% |
| 2022 | 10.49% |
| 2021 | 48.33% |
| 2020 | 65.98% |
| 2019 | 79.67% |
| 2018 | 27.10% |
| 2017 | 54.50% |
| 2016 | -4.09% |